Trial Outcomes & Findings for Reproductive Outcome Affected by Two Adjunctive Treatments in Patients With Severe Intrauterine Adhesions (NCT NCT02708277)
NCT ID: NCT02708277
Last Updated: 2016-05-27
Results Overview
COMPLETED
NA
93 participants
three years
2016-05-27
Participant Flow
From January 2011 to February 2013, women with severe intrauterine adhesions who presented with a history of infertility were initially included in the study.
Exclusion criteria: endometrial tuberculosis, grossly abnormal semen analysis, ovarian failure, hydrosalpinx fluid, and patients who did not proceed to second-look hysteroscopy within the specified time frame,women with no desire to pregnancy.
Participant milestones
| Measure |
Loop-shaped Intrauterine Device Group
At the end of the procedure the surgery loop-shaped intrauterine contraceptive device (IUCD) was placed in the uterine cavity.
loop-shaped intrauterine contraceptive device: Intrauterine contraceptive device can temporary protective layer between the endometrium wound during the most critical three weeks after the surgery to prevent adhesion reformation.
|
Intrauterine Balloon Group
At the end of the procedure the surgery an intrauterine balloon (Cook Medical) was placed in the uterine cavity.
intrauterine balloon (Cook Medical): The balloons used in this study is heart- shaped that resembled the shape of the uterine cavity and could fully separate the two sides of the uterine wall and the corners of the uterus compare to loop-shaped intrauterine contraceptive device.
|
|---|---|---|
|
Overall Study
STARTED
|
50
|
43
|
|
Overall Study
COMPLETED
|
43
|
39
|
|
Overall Study
NOT COMPLETED
|
7
|
4
|
Reasons for withdrawal
| Measure |
Loop-shaped Intrauterine Device Group
At the end of the procedure the surgery loop-shaped intrauterine contraceptive device (IUCD) was placed in the uterine cavity.
loop-shaped intrauterine contraceptive device: Intrauterine contraceptive device can temporary protective layer between the endometrium wound during the most critical three weeks after the surgery to prevent adhesion reformation.
|
Intrauterine Balloon Group
At the end of the procedure the surgery an intrauterine balloon (Cook Medical) was placed in the uterine cavity.
intrauterine balloon (Cook Medical): The balloons used in this study is heart- shaped that resembled the shape of the uterine cavity and could fully separate the two sides of the uterine wall and the corners of the uterus compare to loop-shaped intrauterine contraceptive device.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
7
|
4
|
Baseline Characteristics
Reproductive Outcome Affected by Two Adjunctive Treatments in Patients With Severe Intrauterine Adhesions
Baseline characteristics by cohort
| Measure |
Group A
n=43 Participants
At the end of the procedure the surgery loop-shaped intrauterine contraceptive device (IUCD) was placed in the uterine cavity.
loop-shaped intrauterine contraceptive device: Intrauterine contraceptive device can temporary protective layer between the endometrium wound during the most critical three weeks after the surgery to prevent adhesion reformation.
|
Group B
n=39 Participants
At the end of the procedure the surgery an intrauterine balloon (Cook Medical) was placed in the uterine cavity.
intrauterine balloon (Cook Medical): The balloons used in this study is heart- shaped that resembled the shape of the uterine cavity and could fully separate the two sides of the uterine wall and the corners of the uterus compare to loop-shaped intrauterine contraceptive device.
|
Total
n=82 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
43 Participants
n=5 Participants
|
39 Participants
n=7 Participants
|
82 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
32.3 years
STANDARD_DEVIATION 4.3 • n=5 Participants
|
31.6 years
STANDARD_DEVIATION 4.3 • n=7 Participants
|
31.9 years
STANDARD_DEVIATION 4.3 • n=5 Participants
|
|
Sex: Female, Male
Female
|
43 Participants
n=5 Participants
|
39 Participants
n=7 Participants
|
82 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
China
|
43 participants
n=5 Participants
|
39 participants
n=7 Participants
|
82 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: three yearsOutcome measures
| Measure |
Loop-shaped Intrauterine Device Group
n=43 Participants
At the end of the procedure the surgery loop-shaped intrauterine contraceptive device (IUCD) was placed in the uterine cavity.
loop-shaped intrauterine contraceptive device: Intrauterine contraceptive device can temporary protective layer between the endometrium wound during the most critical three weeks after the surgery to prevent adhesion reformation.
|
Intrauterine Balloon Group
n=39 Participants
At the end of the procedure the surgery an intrauterine balloon (Cook Medical) was placed in the uterine cavity.
intrauterine balloon (Cook Medical): The balloons used in this study is heart- shaped that resembled the shape of the uterine cavity and could fully separate the two sides of the uterine wall and the corners of the uterus compare to loop-shaped intrauterine contraceptive device.
|
|---|---|---|
|
Number of Participants With Pregnancy in Loop-shaped Intrauterine Device Group and Intrauterine Balloon Group
|
12 participants
|
22 participants
|
SECONDARY outcome
Timeframe: Within the first 3 months after surgeryComparing with preoperative and postoperative menstrual duration, numbers of sanitary napkin using and wet area ratio of sanitary napkin to judgment whether menstrual quantity is improvement in patients
Outcome measures
| Measure |
Loop-shaped Intrauterine Device Group
n=43 Participants
At the end of the procedure the surgery loop-shaped intrauterine contraceptive device (IUCD) was placed in the uterine cavity.
loop-shaped intrauterine contraceptive device: Intrauterine contraceptive device can temporary protective layer between the endometrium wound during the most critical three weeks after the surgery to prevent adhesion reformation.
|
Intrauterine Balloon Group
n=39 Participants
At the end of the procedure the surgery an intrauterine balloon (Cook Medical) was placed in the uterine cavity.
intrauterine balloon (Cook Medical): The balloons used in this study is heart- shaped that resembled the shape of the uterine cavity and could fully separate the two sides of the uterine wall and the corners of the uterus compare to loop-shaped intrauterine contraceptive device.
|
|---|---|---|
|
Menstruation Pattern(Improvement or No Significant Change) of All Participants
Menstruation pattern improvement
|
35 participants
|
28 participants
|
|
Menstruation Pattern(Improvement or No Significant Change) of All Participants
Menstruation pattern no significant change
|
8 participants
|
11 participants
|
SECONDARY outcome
Timeframe: Within the first 3 months after surgeryOutcome measures
| Measure |
Loop-shaped Intrauterine Device Group
n=43 Participants
At the end of the procedure the surgery loop-shaped intrauterine contraceptive device (IUCD) was placed in the uterine cavity.
loop-shaped intrauterine contraceptive device: Intrauterine contraceptive device can temporary protective layer between the endometrium wound during the most critical three weeks after the surgery to prevent adhesion reformation.
|
Intrauterine Balloon Group
n=39 Participants
At the end of the procedure the surgery an intrauterine balloon (Cook Medical) was placed in the uterine cavity.
intrauterine balloon (Cook Medical): The balloons used in this study is heart- shaped that resembled the shape of the uterine cavity and could fully separate the two sides of the uterine wall and the corners of the uterus compare to loop-shaped intrauterine contraceptive device.
|
|---|---|---|
|
Endometrial Thickness of All Participants in the Mid Menstrual Measured by Color Doppler Ultrasound
|
6.1 mm
Standard Deviation 1.8
|
6.1 mm
Standard Deviation 1.7
|
SECONDARY outcome
Timeframe: Within the first 3 months after surgeryOutcome measures
| Measure |
Loop-shaped Intrauterine Device Group
n=43 Participants
At the end of the procedure the surgery loop-shaped intrauterine contraceptive device (IUCD) was placed in the uterine cavity.
loop-shaped intrauterine contraceptive device: Intrauterine contraceptive device can temporary protective layer between the endometrium wound during the most critical three weeks after the surgery to prevent adhesion reformation.
|
Intrauterine Balloon Group
n=39 Participants
At the end of the procedure the surgery an intrauterine balloon (Cook Medical) was placed in the uterine cavity.
intrauterine balloon (Cook Medical): The balloons used in this study is heart- shaped that resembled the shape of the uterine cavity and could fully separate the two sides of the uterine wall and the corners of the uterus compare to loop-shaped intrauterine contraceptive device.
|
|---|---|---|
|
Number of Participants With Reformation of Intrauterine Adhesions in Loop-shaped Intrauterine Device Group and Intrauterine Balloon Group
Reformation of intrauterine adhesions
|
16 participants
|
6 participants
|
|
Number of Participants With Reformation of Intrauterine Adhesions in Loop-shaped Intrauterine Device Group and Intrauterine Balloon Group
Peripheral adhesions
|
13 participants
|
4 participants
|
|
Number of Participants With Reformation of Intrauterine Adhesions in Loop-shaped Intrauterine Device Group and Intrauterine Balloon Group
Central adhesions
|
1 participants
|
2 participants
|
|
Number of Participants With Reformation of Intrauterine Adhesions in Loop-shaped Intrauterine Device Group and Intrauterine Balloon Group
Mixed adhesions
|
2 participants
|
0 participants
|
Adverse Events
Loop-shaped Intrauterine Device Group
Intrauterine Balloon Group
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Loop-shaped Intrauterine Device Group
n=43 participants at risk
At the end of the procedure the surgery loop-shaped intrauterine contraceptive device (IUCD) was placed in the uterine cavity.
loop-shaped intrauterine contraceptive device: Intrauterine contraceptive device can temporary protective layer between the endometrium wound during the most critical three weeks after the surgery to prevent adhesion reformation.
|
Intrauterine Balloon Group
n=39 participants at risk
At the end of the procedure the surgery an intrauterine balloon (Cook Medical) was placed in the uterine cavity.
intrauterine balloon (Cook Medical): The balloons used in this study is heart- shaped that resembled the shape of the uterine cavity and could fully separate the two sides of the uterine wall and the corners of the uterus compare to loop-shaped intrauterine contraceptive device.
|
|---|---|---|
|
Infections and infestations
vaginitis
|
2.3%
1/43 • Number of events 1
|
2.6%
1/39 • Number of events 1
|
Additional Information
Yuqing Chen
The First Affiliated Hospital of Sun Yat-sen University
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place